ProQR Therapeutics (PRQR) Return on Capital Employed Growth (5y) (2019 - 2026)

ProQR Therapeutics (PRQR) Return on Capital Employed Growth (5y) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 ProQR Therapeutics 219.53 Mn 175.72 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -6,525.00
Dec 31, 2025 -546.00
Sep 30, 2025 744.00
Jun 30, 2025 1,910.00
Mar 31, 2025 3,201.00
Dec 31, 2024 3,412.00
Sep 30, 2024 3,433.00
Jun 30, 2024 -3,027.00
Mar 31, 2024 -3,167.00
Dec 31, 2023 -3,013.00
Sep 30, 2023 -3,215.00
Jun 30, 2023 -3,883.00
Mar 31, 2023 -3,899.00
Dec 31, 2021 -3,260.00
Mar 31, 2020 -4,948.00
Dec 31, 2019 -5,431.00